Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Rausch

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Pflugers Archiv : European Journal of Physiology|January 27, 2022
The regulation of FGF23 under physiological and pathophysiological conditionsSteffen Rausch, Michael Föller
Expert Review of Anticancer Therapy|October 27, 2020
Treatment and resistance mechanisms in castration-resistant prostate cancer: new implications for clinical decision making?Valentina Norz, Steffen Rausch
Urology Annals|December 23, 2015
Prostate-specific antigen density as a parameter for the prediction of positive lymph nodes at radical prostatectomyTheocharis Yiakoumos, Tilman Kälble, Steffen Rausch
Urology Annals|February 21, 2012
Nonbilharzial squamous cell carcinoma and transitional cell carcinoma with squamous differentiation of the lower and upper urinary tractSteffen Rausch, Rainer Hofmann, Rolf von Knobloch
Urologic Oncology|February 26, 2013
Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: a contemporary review with focus on nonbilharzial squamous cell carcinomaSteffen Rausch, Yair Lotan, Ramy F Youssef
Nutrition (Burbank, Los Angeles County, Calif.)|September 22, 2020
Vitamin A regulates fibroblast growth factor 23 (FGF23)Steffen Rausch, Michelle Barholz, Michael Föller, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancerSteffen Rausch, Christian Schwentner, Arnulf Stenzl, et al.
Aktuelle Urologie|June 15, 2017
[Reconstructive surgery of the urinary bladder]Susanne Schnürer, Bastian Amend, Arnulf Stenzl, et al.
Future Oncology (London, England)|June 20, 2014
IMA901 for metastatic renal cell carcinoma in the context of new approaches to immunotherapySteffen Rausch, Stephan Kruck, Arnulf Stenzl, et al.
Expert Review of Anticancer Therapy|October 17, 2018
Trimodal therapy for muscle-invasive bladder cancerJoachim Mathes, Steffen Rausch, Tilman Todenhöfer, et al.
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Pflugers Archiv : European Journal of Physiology|January 27, 2022
The regulation of FGF23 under physiological and pathophysiological conditionsSteffen Rausch, Michael Föller
Expert Review of Anticancer Therapy|October 27, 2020
Treatment and resistance mechanisms in castration-resistant prostate cancer: new implications for clinical decision making?Valentina Norz, Steffen Rausch
Urology Annals|December 23, 2015
Prostate-specific antigen density as a parameter for the prediction of positive lymph nodes at radical prostatectomyTheocharis Yiakoumos, Tilman Kälble, Steffen Rausch
Urology Annals|February 21, 2012
Nonbilharzial squamous cell carcinoma and transitional cell carcinoma with squamous differentiation of the lower and upper urinary tractSteffen Rausch, Rainer Hofmann, Rolf von Knobloch
Urologic Oncology|February 26, 2013
Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: a contemporary review with focus on nonbilharzial squamous cell carcinomaSteffen Rausch, Yair Lotan, Ramy F Youssef
Nutrition (Burbank, Los Angeles County, Calif.)|September 22, 2020
Vitamin A regulates fibroblast growth factor 23 (FGF23)Steffen Rausch, Michelle Barholz, Michael Föller, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancerSteffen Rausch, Christian Schwentner, Arnulf Stenzl, et al.
Aktuelle Urologie|June 15, 2017
[Reconstructive surgery of the urinary bladder]Susanne Schnürer, Bastian Amend, Arnulf Stenzl, et al.
Future Oncology (London, England)|June 20, 2014
IMA901 for metastatic renal cell carcinoma in the context of new approaches to immunotherapySteffen Rausch, Stephan Kruck, Arnulf Stenzl, et al.
Expert Review of Anticancer Therapy|October 17, 2018
Trimodal therapy for muscle-invasive bladder cancerJoachim Mathes, Steffen Rausch, Tilman Todenhöfer, et al.
Pageof 13